Pharma-Bio Serv, Inc. (PBSV) Financials
PBSV Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| April 30, 2026 | 11.5 billion | 1.0 billion |
| Jan. 31, 2026 | 13.5 million | 3.3 million |
| Oct. 31, 2025 | 13.7 million | 1.7 million |
| July 31, 2025 | 13.6 million | 1.7 million |
PBSV Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| April 30, 2026 | -365.3 million | 8.6 million |
| Jan. 31, 2026 | -392550 | 8619 |
| Oct. 31, 2025 | 279316 | 4399 |
| July 31, 2025 | 236524 | 9999 |
PBSV Net Income
| Date | Net Income |
|---|---|
| April 30, 2026 | 233.0 million |
| Jan. 31, 2026 | 32860 |
| Oct. 31, 2025 | -102 |
| July 31, 2025 | -204250 |
PBSV Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| April 30, 2026 | 8.5 million | - | - |
| Jan. 31, 2026 | 10.6 million | - | - |
| Oct. 31, 2025 | 10.9 million | - | 28834 |
| July 31, 2025 | 10.7 million | - | 71362 |
PBSV Shares Outstanding
PBSV Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| April 30, 2026 | 2319 | - | 757.4 million | - |
| Jan. 31, 2026 | 2411 | - | 816.9 million | - |
| Oct. 31, 2025 | 350 | - | 882207 | - |
| July 31, 2025 | 2036 | - | 888139 | - |
PBSV Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| April 30, 2026 | 2.7 million | 1.8 million |
| Jan. 31, 2026 | 2.3 million | 1.6 million |
| Oct. 31, 2025 | 2.1 million | 1.4 million |
| July 31, 2025 | 2.0 million | 1.4 million |
PBSV
Price: $0.50
Dividend Yield: 13.16%
Forward Dividend Yield: 15.00%
Payout Ratio: 250.00%
Dividend Per Share: 0.08 USD
Earnings Per Share: -0.01 USD
P/E Ratio: -49
Exchange: OQB
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 44500
Market Capitalization: 13.1 million
Average Dividend Frequency: 1
Years Paying Dividends: 4